08 January 2010
Hypothyroidism and simvastatin as a combined cause of rhabdomyolysis acute renal failure
Amr El-Husseini, Rama Chemitiganti, James BurksAm J Case Rep 2010; 11:7-9 :: ID: 878326
Abstract
Background: Rhabdomyolysis is a syndrome characterized by muscle necrosis and the release of intracellular muscle contents into the systemic circulation. Most commonly, the cause of rhabdomyolysis can be determined from the pathogenesis or from the immediate circumstances preceding the disorder, such as postoperative surgical trauma, a comatose or postictal state, or extra-ordinary physical exertion. Occasionally, the cause will not be obvious. Some of these cases are due to heritable muscle enzyme deficiencies, electrolyte abnormalities, infections, drugs, toxins, or endocrinopathies.
Case Report: Herein, we describe a 44-year-old Hispanic patient with no previous medical history apart from hyperlipidemia and undiagnosed hypothyroidism. He developed rhabdomyolysis and acute kidney injury after starting low dose simvastatin without any other precipitating factors. The statin was stopped, intravenous fluids were started immediately and L-thyroxine was given after confirming the diagnosis of hypothyroidism. His symptoms and kidney function improved over a few weeks after increasing L-thyroxine daily dose to 1.5 mcg/kg.
Conclusions: Because rhabdomyolysis is a rare but potentially life threatening disorder when complicated by acute tubular necrosis and renal failure, physicians must pay special attention when starting statins in patients with hyperlipidemia. Screening thyroid function before starting statins could be rational to avoid this rare but serious complication.
Keywords: rhabdomyolysis, Hypothyroidism, myopathy, case report
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947344
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946589
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947316
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947693
Most Viewed Current Articles
21 Jun 2024 : Case report
100,250
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,680
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,071
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
24,897
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200